Purple Biotech Ltd.

NASDAQ:PPBT

2.21 (USD) • At close May 9, 2025
Bedrijfsnaam Purple Biotech Ltd.
Symbool PPBT
Munteenheid USD
Prijs 2.205
Beurswaarde 30,290
Dividendpercentage 0%
52-weken bereik 2 - 20.6
Industrie Biotechnology
Sector Healthcare
CEO Mr. Isaac Israel
Website https://purple-biotech.com

An error occurred while fetching data.

Over Purple Biotech Ltd.

Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which

Vergelijkbare Aandelen

Biotricity, Inc. logo

Biotricity, Inc.

BTCY

0.337 USD

Molecular Templates, Inc. logo

Molecular Templates, Inc.

MTEM

0 USD

Black Diamond Therapeutics, Inc. logo

Black Diamond Therapeutics, Inc.

BDTX

1.64 USD

MEI Pharma, Inc. logo

MEI Pharma, Inc.

MEIP

2.045 USD

Pro-Dex, Inc. logo

Pro-Dex, Inc.

PDEX

44.29 USD

Hepion Pharmaceuticals, Inc. logo

Hepion Pharmaceuticals, Inc.

HEPA

0.392 USD

Biodesix, Inc. logo

Biodesix, Inc.

BDSX

0.372 USD

Medicenna Therapeutics Corp. logo

Medicenna Therapeutics Corp.

MDNA

0.157 USD

Pulse Biosciences, Inc. logo

Pulse Biosciences, Inc.

PLSE

17.07 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)